Jefferies raised the firm’s price target on Sage Group (SGPYY) to 1,600 GBp from 1,500 GBp and keeps a Buy rating on the shares. The “most ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

John will focus on leading borrower retention efforts and has prior industry experience with Freedom Mortgage, Newrez and ...

When it comes to herbs, sage often takes a back seat to more commonly used seasonings like basil, rosemary, and thyme.

In a report released today, Charles Brennan from Jefferies maintained a Buy rating on Sage Group plc (SGE – Research Report), with a price ...

Through this new integration, government customers can securely train a number of supported AI models using curated Threat ...

The Tyneside-based FTSE100 firm issued first quarter trading results for the three months to the end of December which showed ...

Sage Therapeutics said on Monday that its board has unanimously rejected Biogen’s $469 million offer, stating it ...

Sage Sotheby’s International Realty expands into Kansas City with the acquisition of Element Sotheby’s, strengthening its ...

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...

Sage Group PLC closed 1.08% below its 52-week high of £13.42, which the company achieved on January 22nd.